VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

8235	Companies
111177	Keywords
52887	Articles
61025	Press releases

Home
Companies
VALNEVA

BRIEF

published on 08/30/2024 at 11:06, 2 months 10 days ago

Valneva SE Crosses Threshold

Voting Rights Stock Market Valneva SE Threshold Crossing Grimaud Group
BRIEF

published on 08/30/2024 at 11:06, 2 months 10 days ago

Franchissement de seuil pour Valneva SE

Droits De Vote Franchissement De Seuil Marché Des Actions Valneva SE Groupe Grimaud
PRESS RELEASE

published on 08/30/2024 at 11:01, 2 months 10 days ago

Franchissement de seuil
Déclaration de franchissement de seuil par Groupe Grimaud La Corbière pour VALNEVA SE

Déclaration Franchissement De Seuil AMF Valneva SE Groupe Grimaud La Corbière
PRESS RELEASE

published on 08/22/2024 at 10:51, 2 months 18 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH hat ein Research Update zu Valneva SE veröffentlicht. Analyst Simon Scholes behält seine Kaufempfehlung bei und bestätigt das Kursziel von EUR 8,60

First Berlin Equity Research Research Update Kaufempfehlung Aktienanalyse Valneva
BRIEF

published on 08/20/2024 at 16:06, 2 months 20 days ago

First Berlin Equity Research Reiterates Buy Rating for Valneva SE

Valneva Equity Research Market Undervaluation H1 Results Lyme Vaccine
BRIEF

published on 08/20/2024 at 16:06, 2 months 20 days ago

First Berlin Equity Research réitère sa recommandation d'achat pour Valneva SE

Valneva Recherche Sur Les Actions Vaccin Contre La Maladie De Lyme Sous-évaluation Du Marché Résultats H1
PRESS RELEASE

published on 08/20/2024 at 16:01, 2 months 20 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates research on Valneva SE (ISIN: FR0004056851) with a BUY recommendation and EUR 8.60 price target. H1 product sales slightly below consensus but gross margin improving. Valneva maintains full-year guidance

First Berlin Equity Research Buy Recommendation Valneva SE EUR 8.60 Price Target H1 Product Sales
BRIEF

published on 08/13/2024 at 07:05, 2 months 27 days ago

Valneva publie ses résultats financiers du premier semestre 2024 et fournit des mises à jour sur l'entreprise

Résultats Financiers Valneva Prévisions De Revenus Développement De Vaccins Situation De Trésorerie
BRIEF

published on 08/13/2024 at 07:05, 2 months 27 days ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

Financial Results Cash Position Revenue Guidance Valneva Vaccine Development
PRESS RELEASE

published on 08/13/2024 at 07:00, 2 months 27 days ago

Valneva publie ses résultats financiers du premier semestre 2024 et fait un point sur ses activités

Accesswire

Published on 11/10/2024 at 02:00, 4 hours 2 minutes ago

Spey Resources Corp. enters into Share Exchange Agreement with Antimony Assets and announces Name Change
Published on 11/09/2024 at 16:30, 13 hours 32 minutes ago

New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Published on 11/09/2024 at 04:00, 1 day 2 hours ago

Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Published on 11/08/2024 at 23:05, 1 day 6 hours ago

Murchison Minerals Announces Non-Brokered Private Placement
Published on 11/08/2024 at 22:30, 1 day 7 hours ago

Justera Health Announces RSU Grant

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 18:35, 1 day 11 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 1 day 11 hours ago

ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:15, 1 day 11 hours ago

EQS-Adhoc: ENCAVIS AG
Published on 11/08/2024 at 18:02, 1 day 11 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 1 day 12 hours ago

2CRSi SA: Provision of the Financial Report

Les Echos

Published on 11/08/2024 at 18:00, 1 day 12 hours ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 11/08/2024 at 18:00, 1 day 12 hours ago

Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 1 day 12 hours ago

Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:52, 1 day 12 hours ago

Capital et droits de vote au 31 octobre 2024
Published on 11/08/2024 at 17:45, 1 day 12 hours ago

CHARGEURS - Voting rights monthly statement as of October 31st, 2024

View all LES ECHOS COMFI WIRE